1. Home
  2. TYRA vs EVER Comparison

TYRA vs EVER Comparison

Compare TYRA & EVER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TYRA
  • EVER
  • Stock Information
  • Founded
  • TYRA 2018
  • EVER 2008
  • Country
  • TYRA United States
  • EVER United States
  • Employees
  • TYRA N/A
  • EVER N/A
  • Industry
  • TYRA Biotechnology: Pharmaceutical Preparations
  • EVER Computer Software: Programming Data Processing
  • Sector
  • TYRA Health Care
  • EVER Technology
  • Exchange
  • TYRA Nasdaq
  • EVER Nasdaq
  • Market Cap
  • TYRA 844.2M
  • EVER 929.6M
  • IPO Year
  • TYRA 2021
  • EVER 2018
  • Fundamental
  • Price
  • TYRA $14.27
  • EVER $25.34
  • Analyst Decision
  • TYRA Strong Buy
  • EVER Strong Buy
  • Analyst Count
  • TYRA 5
  • EVER 5
  • Target Price
  • TYRA $31.20
  • EVER $31.80
  • AVG Volume (30 Days)
  • TYRA 261.6K
  • EVER 637.8K
  • Earning Date
  • TYRA 11-05-2025
  • EVER 11-03-2025
  • Dividend Yield
  • TYRA N/A
  • EVER N/A
  • EPS Growth
  • TYRA N/A
  • EVER 284.14
  • EPS
  • TYRA N/A
  • EVER 1.44
  • Revenue
  • TYRA N/A
  • EVER $644,656,000.00
  • Revenue This Year
  • TYRA N/A
  • EVER $32.27
  • Revenue Next Year
  • TYRA N/A
  • EVER $11.05
  • P/E Ratio
  • TYRA N/A
  • EVER $17.68
  • Revenue Growth
  • TYRA N/A
  • EVER 57.83
  • 52 Week Low
  • TYRA $6.42
  • EVER $16.63
  • 52 Week High
  • TYRA $17.78
  • EVER $30.03
  • Technical
  • Relative Strength Index (RSI)
  • TYRA 49.37
  • EVER 71.83
  • Support Level
  • TYRA $13.35
  • EVER $19.15
  • Resistance Level
  • TYRA $15.38
  • EVER $25.95
  • Average True Range (ATR)
  • TYRA 0.92
  • EVER 0.97
  • MACD
  • TYRA -0.14
  • EVER 0.73
  • Stochastic Oscillator
  • TYRA 35.37
  • EVER 90.95

About TYRA Tyra Biosciences Inc.

Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are TYRA-300, TYRA-200, and TYRA-430: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.

About EVER EverQuote Inc.

EverQuote Inc is engaged in the business activity of offering an online marketplace for insurance shopping, connecting consumers with insurance provider customers, which includes both carriers and agents. The online marketplace offers consumers to find relevant insurance quotes based on car insurance, home insurance, and life insurance. The platform of the company is driven by data science. The firm's data and technology platform match and connects consumers seeking to purchase insurance with relevant options from its broad direct network of insurance providers. It derives a majority of revenue from Direct channels.

Share on Social Networks: